| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Pathology*
and
Dermatology,
University of Kiel, Kiel,
Germany; the Institute of Dermatopathology,
Buchholz, Germany; and the Department of
Dermatology,§
University of Warsaw,
Warsaw, Poland
Telomerase activation, being a cardinal requirement for immortalization, is a crucial step in the development of malignancy. With a view toward diagnostic and biological aspects in melanocytic neoplasia, we investigated the relative levels of telomerase activity in 72 nevi and 16 malignant melanomas by means of a modified telomeric repeat amplification protocol (TRAP) assay, including an internal amplification standard. We further compared telomerase activity with the expression of two different proliferation-specific proteins, Ki-67 and repp86, a protein expressed exclusively in the cell cycle phases S, G2, and M. Telomerase activity was associated with the overall growth fraction (Ki-67) but showed a closer correlation with the expression of repp86. Both telomerase activity and proliferation indices discriminated clearly between malignant melanomas and nevi, but not between common and dysplastic nevi. Nonetheless, a portion of nevi exhibited markedly elevated telomerase activity levels without proportionally increased proliferation. This was independent of discernible morphological changes. Clinicopathological correlations showed an association between high telomerase activity and early metastatic spread in melanomas, linking telomerase to tumor biology. Our results provide arguments in favor of an occasional progression from nevi to melanomas and imply that proliferation measurements in combination with telomerase assays may help to elicit early malignant transformation that is undetectable by conventional morphology.
This article has been cited by other articles:
 |
|
 |
|
  Y. Ma, D. Lin, W. Sun, T. Xiao, J. Yuan, N. Han, S. Guo, X. Feng, K. Su, Y. Mao, et al. Expression of Targeting Protein for Xklp2 Associated with Both Malignant Transformation of Respiratory Epithelium and Progression of Squamous Cell Lung Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1121 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M R Hussein Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues J. Clin. Pathol., May 1, 2005; 58(5): 453 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Krams, H.-J. Heidebrecht, B. Hero, F. Berthold, D. Harms, R. Parwaresch, and P. Rudolph repp86 Expression and Outcome in Patients With Neuroblastoma J. Clin. Oncol., May 1, 2003; 21(9): 1810 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Govindarajan, X. Bai, C. Cohen, H. Zhong, S. Kilroy, G. Louis, M. Moses, and J. L Arbiser Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling J. Biol. Chem., March 7, 2003; 278(11): 9790 - 9795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Krams, B. Hero, F. Berthold, R. Parwaresch, D. Harms, and P. Rudolph Full-Length Telomerase Reverse Transcriptase Messenger RNA Is an Independent Prognostic Factor in Neuroblastoma Am. J. Pathol., March 1, 2003; 162(3): 1019 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Heidebrecht, S. Adam-Klages, M. Szczepanowski, M. Pollmann, F. Buck, E. Endl, M.-L. Kruse, P. Rudolph, and R. Parwaresch repp86: A Human Protein Associated in the Progression of Mitosis Mol. Cancer Res., February 1, 2003; 1(4): 271 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Krams, A. Claviez, K. Heidorn, G. Krupp, R. Parwaresch, D. Harms, and P. Rudolph Regulation of Telomerase Activity by Alternate Splicing of Human Telomerase Reverse Transcriptase mRNA in a Subset of Neuroblastomas Am. J. Pathol., November 1, 2001; 159(5): 1925 - 1932. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
